Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin?s Lymphoma

被引:2
|
作者
Veeraballi, Sindhusha [1 ]
Mirza, Noreen [1 ]
Khawar, Zaineb [2 ]
Shaaban, Hamid [3 ]
机构
[1] St Michaels Hosp, Internal Med, Newark, NJ 19403 USA
[2] St Georges Univ, Sch Med, Internal Med, Newark, NJ USA
[3] St Michaels Hosp, Hematol Oncol, Newark, NJ USA
关键词
nodular subtype hodgkin' s lymphoma; cancer prognosis; tumor transformation; hodgkin's lymphoma; marginal zone lymphoma;
D O I
10.7759/cureus.26738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is defined as sheets of large cells arising in an indolent lymphoma with morphological and immunophenotypic changes suggestive of a high-grade lymphoma such as Hodgkin's lymphoma, diffuse large B cell lymphoma (DLBCL), or Burkitt lymphoma. The median time of transformation ranges from one year to 15 years following the initial diagnosis of MZL. Studies reported that the deletion of TP53 and 7q and mutations in NOTCH2 are commonly associated with HT in MZL. This case report outlines the rare happening of an MZL transformation into a nodular subtype of Hodgkin's lymphoma in a 56-year-old female, which prompted further investigations and a different therapeutic approach. By reporting this case, we emphasize that HT changes the natural history and significantly affects the overall survival of patients with MZL. Hence, it is necessary to get a core needle or excisional biopsy whenever there is a clinical suspicion of HT in MZL for early diagnosis and a better therapeutic approach.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Comparison of immunohistochemical staining of splenic marginal zone hyperplasia and splenic marginal zone lymphoma
    Fillman, EP
    Burton, MP
    Ehsan, A
    Neuhauser, TS
    MODERN PATHOLOGY, 2003, 16 (01) : 232A - 232A
  • [32] An insidious presentation of splenic marginal zone lymphoma
    Burcheri, Sara
    Arcaini, Luca
    Della Porta, Mattec
    Paulli, Marco
    Boveri, Emanuela
    Zibellini, Silvia
    Rumi, Elisa
    Algarotti, Alessandra
    Passamouti, Francesco
    Lazzarino, Mario
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (06): : 432 - 433
  • [33] IMMUNOPHENOTYPIC PROFILE OF SPLENIC MARGINAL ZONE LYMPHOMA
    Kakkas, I.
    Karmiris, T.
    Psarra, K.
    Kapsimali, V.
    Grigoriou, I.
    Delibasi, S.
    Gigantes, S.
    Pagoni, M.
    Tasidou, A.
    Rontogianni, D.
    Bakiri, M.
    Harhalakis, N.
    Nikiforakis, E.
    Papasteriades, C.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 406 - 407
  • [34] Tissue proteomics of splenic marginal zone lymphoma
    Polati, Rita
    Brandi, Jessica
    Dalai, Irene
    Zamo, Alberto
    Cecconi, Daniela
    ELECTROPHORESIS, 2015, 36 (14) : 1612 - 1621
  • [35] Rituximab monotherapy in splenic marginal zone lymphoma
    Bennett, M.
    Dave, H. P.
    Dann, E. J.
    Yegena, S.
    Chubar, E.
    Schechter, G. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 228 - 228
  • [36] Prolymphocytic progression of splenic marginal zone lymphoma
    Parts-Martin, Concepcion
    Morales-Camacho, Rosario M.
    BLOOD, 2025, 145 (10) : 1097 - 1097
  • [37] Surgical management of splenic marginal zone lymphoma
    Kennedy, N. D.
    Le, G. N.
    Kelly, M. E.
    Harding, T.
    Fadalla, K.
    Winter, D. C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (02) : 343 - 347
  • [38] Surgical management of splenic marginal zone lymphoma
    N. D. Kennedy
    G. N. Lê
    M. E. Kelly
    T. Harding
    K. Fadalla
    D. C. Winter
    Irish Journal of Medical Science (1971 -), 2018, 187 : 343 - 347
  • [39] CYTOGENETIC CHARACTERISTICS OF SPLENIC MARGINAL ZONE LYMPHOMA
    Julhakyan, H. L.
    Obukhova, T. N.
    Savchenko, V. G.
    HAEMATOLOGICA, 2014, 99 : 690 - 690
  • [40] Primary Splenic and Nodal Marginal Zone Lymphoma
    Diebold, Jacques
    Le Tourneau, Agnes
    Comperat, Eva
    Molina, Thierry
    Jose e Audouin
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2005, 45 (01) : 1 - 14